PAG MEETING (2022 I)
Date, time
Thu, Jan 1 1970, 0:00 - Thu, Jan 1 1970, 0:00
Location
Price
25 April 2022 (EET)
Vilnius, Hotel Artis
14:00 - 14:10
Welcome of TREL project coordinator
14:10 - 14:30
WP2. SIOPE
14:30 - 14:50
WP3. St. Anna Children’s Cancer Research Institute
14:50 - 15:10
WP4. Rigshospitalet
15:10 - 15:30
WP5. University Medical Center Hamburg-Eppendorf
15:30 - 15:50
Coffee break
15:50 - 16:10
WP6. Istituto Giannina Gaslini
16:10 - 16:30
WP7. Institut Gustave Roussy
16:30 - 16:50
WP1 VULSK
16:50 - 17:00
Discussion, closure of the meeting
17:30 – 19:00
Networking event (TBD)
19:00 – 22:00
Dinner
26 April 2022 (EET time)
Vilnius, venue VULSK
09:00 – 10:30
VULSK visit, meeting twinning peers
10:30 – 11:00
Welcome coffee and registration
11:00 – 13:00
Paediatric CNS tumours
Phase III clinical trials in CNS tumours (UKE) Stefan Rutkowski
Early phase trials in CNS tumours (REGIONH) Karsten Nysom
Tumor response assessments (e. g. RANO / RAPNO1 for pHGG, DIPG, LGG2 (IGR) Samuel Abbou
Preparedness of Radiology service of VULSK to clinical trials. Irina Adomaitiene
Phase III clinical trials in CNS tumours (UKE) Stefan Rutkowski
Early phase trials in CNS tumours (REGIONH) Karsten Nysom
Tumor response assessments (e. g. RANO / RAPNO1 for pHGG, DIPG, LGG2 (IGR) Samuel Abbou
Preparedness of Radiology service of VULSK to clinical trials. Irina Adomaitiene
13:00 – 14:00
Lunch
14:00 – 16:00
Neuroblastoma
Biology for risk stratification in NBL clinical trials (CCRI). Sabine Taschner-Mandl.
The value of molecular tumour board for the management of relapsed/refractory disease (IGR). Birgit Geoerger.
Late effects research in NB (IGG). Riccardo Haupt.
Implementation of in NB clinical trials - VULSK perspectives. Rimvydas Norvilas
Biology for risk stratification in NBL clinical trials (CCRI). Sabine Taschner-Mandl.
The value of molecular tumour board for the management of relapsed/refractory disease (IGR). Birgit Geoerger.
Late effects research in NB (IGG). Riccardo Haupt.
Implementation of in NB clinical trials - VULSK perspectives. Rimvydas Norvilas
16:00 – 16:15
Coffee break
16:15 – 18:00
Pediatric Renal tumours
UMBRELLA protocol (PMC). Marry van den Heuvel-Eibrink.
Pathology/biology/radiology in renal tumours PMC TBD.
VULSK. Pediatric renal tumours in Lithuania. Rolanda Nemaniene
UMBRELLA protocol (PMC). Marry van den Heuvel-Eibrink.
Pathology/biology/radiology in renal tumours PMC TBD.
VULSK. Pediatric renal tumours in Lithuania. Rolanda Nemaniene
18:00 – 21:00
Networking event / Farewell dinner